Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,302 papers from all fields of science
Search
Sign In
Create Free Account
Ovarian Serous Adenocarcinoma
Known as:
Ovarian Serous Carcinoma
, Serous Adenocarcinoma of Ovary
, Serous Adenocarcinoma of the Ovary
Expand
An adenocarcinoma that arises from the ovary and is characterized by the presence of malignant epithelial cells that, in well differentiated tumors…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Adenocarcinoma Cell with Intracytoplasmic Mucin
Endometrial Carcinoma
Epithelial Cells
Epithelium
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Prognostic Impact of the Cancer Stem Cell–Related Marker NANOG in Ovarian Serous Carcinoma
Maria Lee
,
E. Nam
,
Sang Wun Kim
,
Sunghoon Kim
,
Jae Hoon Kim
,
Young Tae Kim
International Journal of Gynecologic Cancer
2012
Corpus ID: 2415930
Objective The objective of this study was to evaluate the prognostic significance of NANOG expression in ovarian serous carcinoma…
Expand
Highly Cited
2006
Highly Cited
2006
Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer.
L. Solomon
,
A. Munkarah
,
+4 authors
R. Ali-Fehmi
Gynecologic Oncology
2006
Corpus ID: 8972857
2006
2006
Sustained response to bevacizumab in refractory well-differentiated ovarian neoplasms.
M. Bidus
,
J. Webb
,
J. Seidman
,
G. Rose
,
C. Boice
,
J. Elkas
Gynecologic Oncology
2006
Corpus ID: 10280828
Highly Cited
2003
Highly Cited
2003
beta-catenin nuclear localization is associated with grade in ovarian serous carcinoma.
Christine M. Lee
,
Hyun S. Shvartsman
,
+9 authors
K. Lu
Gynecologic Oncology
2003
Corpus ID: 35820716
Highly Cited
2003
Highly Cited
2003
Glycodelin in ovarian serous carcinoma: association with differentiation and survival.
E. Mandelin
,
H. Lassus
,
+5 authors
R. Koistinen
Cancer Research
2003
Corpus ID: 6215338
Ovarian cancer consists of many subtypes, serous carcinoma being the most common of them. In addition to the histopathological…
Expand
Highly Cited
2001
Highly Cited
2001
Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
B. Davidson
,
P. Lazarovici
,
+8 authors
R. Reich
Clinical Cancer Research
2001
Corpus ID: 553840
PURPOSE The purpose of this study was to analyze the expression of the high- and low-affinity nerve growth factor (NGF) receptors…
Expand
2000
2000
Micropapillary variant of transitional cell carcinoma of the ureter
Y. Oh
,
Kyu Rae Kim
Pathology international (Print)
2000
Corpus ID: 30655439
Micropapillary variant of transitional cell carcinoma (TCC) is a rare entity, having a distinct micropapillary component…
Expand
Review
1998
Review
1998
Clear cell carcinoma of the ovary: poor prognosis compared to serous carcinoma.
J. Tammela
,
J. Geisler
,
P. Eskew
,
H. E. Geisler
European Journal of Gynaecological Oncology
1998
Corpus ID: 23429783
BACKGROUND A review of literature comparing the survival of patients with clear cell carcinoma of the ovary to patients with…
Expand
Highly Cited
1996
Highly Cited
1996
Neoadjuvant chemotherapy in uterine papillary serous carcinoma.
E. Resnik
,
Jerome B. Taxy
Gynecologic Oncology
1996
Corpus ID: 40219366
Uterine papillary serous carcinoma (UPSC) is an aggressive variant of endometrial cancer that frequently imitates serous…
Expand
1981
1981
Progressive chromosome changes associated with different sites of one ovarian carcinoma.
C. Kusyk
,
J. Seski
,
W. Medlin
,
C. Edwards
Journal of the National Cancer Institute
1981
Corpus ID: 27271669
Karyotype analyses were done on cells from the primary and metastatic sites, as well as on the ascitic fluid, from 1 patient with…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required